Signet Financial Management’s Gilead Sciences GILD Stock Holding History

Signet Financial Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-997	Closed	-$72K	–	652
2021 Q4	$72K	Buy	+997	New	+$68.7K	0.01%	381
2018 Q4	–	Sell	-400	Closed	-$31K	–	453
2018 Q3	$31K	Sell	400 -1	-0.2%	-$76	0.01%	458
2018 Q2	$28K	Sell	401 -100	-20%	-$7.06K	﹤0.01%	471
2018 Q1	$38K	Buy	+501	New	+$39.8K	0.01%	388
2016 Q3	–	Sell	-59,404	Closed	-$4.96M	–	177
2016 Q2	$4.96M	Sell	59,404 -9,800	-14%	-$870K	1.15%	38
2016 Q1	$6.36M	Sell	69,204 -6,705	-9%	-$605K	1.34%	26
2015 Q4	$7.68M	Buy	75,909 +6,735	+10%	+$701K	1.57%	23
2015 Q3	$6.79M	Buy	69,174 +13,340	+24%	+$1.48M	1.54%	21
2015 Q2	$6.54M	Buy	55,834 +18,061	+48%	+$1.97M	1.5%	26
2015 Q1	$3.71M	Buy	+37,773	New	+$3.84M	1.03%	49

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Signet Financial Management's GILD Position: Q1 2022 in Review

Signet Financial Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 997 shares — an estimated $72K sold.

Signet Financial Management first reported a position in GILD in Q1 2015 and held it in 10 quarters. The position peaked at $7.68M in Q4 2015. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Signet Financial Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Signet Financial Management sold 997 Gilead Sciences shares in Q1 2022, an estimated $72K.
Signet Financial Management first reported a position in Gilead Sciences in Q1 2015 and held it in 10 quarters.
Signet Financial Management's Gilead Sciences position peaked at $7.68M in Q4 2015.
1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.